Novartis AG
SIX:NOVN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
SIX:NOVN
|
CH |
|
Destinasi Tirta Nusantara Tbk PT
IDX:PDES
|
ID |
|
Lara Exploration Ltd
XTSX:LRA
|
CA |
|
A Plus Asset Advisor Co Ltd
KRX:244920
|
KR |
|
Pfizer Inc
NYSE:PFE
|
US |
|
S
|
Sarawak Oil Palms Bhd
KLSE:SOP
|
MY |
|
S
|
Synergetic Auto Performance PCL
SET:ASAP
|
TH |
|
A
|
Alliance Bank Malaysia Bhd
KLSE:ABMB
|
MY |
Wall Street
Price Targets
NOVN Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for
NOVN
is 126.93 CHF
with a low forecast of 91.91 CHF and a high forecast of 189 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NOVN's stock price target?
Price Target
126.93
CHF
According to Wall Street analysts, the average 1-year price target for
NOVN
is 126.93 CHF
with a low forecast of 91.91 CHF and a high forecast of 189 CHF.
What is Novartis AG's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Novartis AG's revenue is
0%.
The projected
CAGR
for the next 3 years is
5%.
What is Novartis AG's Operating Income forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Novartis AG's operating income is
4%.
The projected
CAGR
for the next 3 years is
9%.
What is Novartis AG's Net Income forecast?
Projected CAGR
14%
For the last 14 years the
compound annual growth rate for
Novartis AG's net income is
3%.
The projected
CAGR
for the next 3 years is
14%.
